DarioHealth Corp. (DRIO)
| Market Cap | 44.16M |
| Revenue (ttm) | 20.35M |
| Net Income (ttm) | -63.51M |
| Shares Out | 29.44M |
| EPS (ttm) | -1.93 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 39,413 |
| Open | 1.480 |
| Previous Close | 1.450 |
| Day's Range | 1.430 - 1.514 |
| 52-Week Range | 0.680 - 4.580 |
| Beta | 1.66 |
| Analysts | Strong Buy |
| Price Target | 5.37 (+258.0%) |
| Earnings Date | May 9, 2024 |
About DRIO
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, wh... [Read more]
Financial Performance
In 2023, DarioHealth's revenue was $20.35 million, a decrease of -26.41% compared to the previous year's $27.66 million. Losses were -$63.51 million, -0.51% less than in 2022.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for DRIO stock is "Strong Buy." The 12-month stock price forecast is $5.37, which is an increase of 258.00% from the latest price.
News
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution
Dario selected to provide integrated and proven solutions to improve employee cardiometabolic health NEW YORK , April 18, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company...
Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health
Studies include a Randomized Controlled Trial demonstrating significant reduction in perceived stress for teens NEW YORK , April 10, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or t...
Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health
Dario selected to provide integrated approach to improve employee cardiometabolic health - including support for those taking a GLP-1 medication - musculoskeletal and behavioral health NEW YORK , Apri...
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
Full-year 2023 revenue of $20.4 million reflects a decrease from 2022 revenue of $7.3 due to a managed decrease in B2C and strategic milestone revenue as the core B2B2C revenue increased. 2023 B2B2C, ...
DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH
Company to host conference call and webcast at 8:30am ET NEW YORK , March 21, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced...
New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications
Study presented at ATTD 2024 is the first of a planned series examining the impact of Dario's integrated cardiometabolic solution as a means to address weight and diabetes with or without a GLP-1 Addi...
DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE
NEW YORK, Feb. 28, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that management will participate in the Cowen 44th Annual Health...
Today's Schedule at The MicroCap Rodeo Winter Wrap Up Conference
Six Top MicroCap CEOs To Watch Live RALEIGH, NC / ACCESSWIRE / February 21, 2024 / On the second day of our virtual conference, the CEOs of the following companies will present: 10:00 AM EST La Rosa H...
Dario acquires Twill creating one of the most comprehensive digital health platform across the most prevalent chronic conditions
Expecting nearly doubling Dario's pro forma revenues in 2023 Acquisition is immediately accretive to revenue and gross margins and expected to accelerate path to profitability Concurrent with the acqu...
Regional Union Selects Dario's Cardiometabolic Solution for Diabetes, Hypertension, Weight Management and GLP-1 Support
Dario's integrated solution to support improved whole health gains traction in public and labor market NEW YORK , Jan. 11, 2024 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Compan...
National Employer Selects Dario Cardiometabolic and GLP-1 Solutions to Improve Employee Health
New client will use Dario's integrated approach to support long-term behavior change for employees living with diabetes, pre-diabetes, hypertension and those taking a GLP-1 medication NEW YORK , Dec. ...
Blue Shield of California's Award-Winning Wellvolution Now More Accessible for Spanish Speakers, Adds New Hypertension Offering
Nonprofit health plan expands services to better meet the healthcare needs of Californians by making it easier to enroll in lifestyle medicine programs at no additional cost OAKLAND, Calif. , Nov. 29,...
Dario Contracts with New Employer for Cardiometabolic Solution
Demand for Dario's integrated cardiometabolic solution continues to grow as employers grappling with the surge in GLP-1 medication utilization search for proven ways to change health behaviors NEW YOR...
New Research Sheds Light on Mediators of Improved Outcomes in Dario Users
Two new analyses associate improved clinical and economic outcomes with use of Dario's digital health solution NEW YORK , Nov. 21, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the...
Dario Publishes New Research Demonstrating that Dario Users That Increased Physical Activity Can Maintain Reduced Blood Glucose
New study highlights the value of a whole health approach managing chronic conditions and supporting members using GLP-1s NEW YORK , Nov. 13, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Da...
DarioHealth Reports Third Quarter 2023 Financial and Operating Results
Third quarter total revenue of $3.52 million compared to $6.6 million in the third quarter of 2022, impacted mainly by lower commercial strategic partners revenues in the quarter of $209,000 as compar...
Dario Launches Apple iPhone 15 Accessible Smart Blood Glucose Meter
New connectivity expands Dario's advantage with consumer accessibility NEW YORK , Nov. 1, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digit...
DarioHealth to Report Third Quarter 2023 Results on Thursday, November 2nd
Company to host conference call and webcast at 8:30am ET NEW YORK , Oct. 30, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that i...
New Research Shows 36% Reduction in 30-Day Hospital Readmission Rate for Dario Users with Type 2 Diabetes
New research demonstrates Dario's ability to reduce costs through lower utilization of expensive healthcare resources, and the winning of a prestigious gold ribbon award NEW YORK , Oct. 17, 2023 /PRNe...
Dario Signs National Preferred Partner Agreement with a Top Five National Employee Benefits Consulting Firm
Agreement names Dario as the preferred digital health provider for employer clients NEW YORK , Oct. 5, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the...
DarioHealth to Host Investor Day on The Rise of Digital Health
In-person event scheduled for Tuesday, October 17, 2023, in New York NEW YORK , Oct. 3, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital...
Dario Publishes New Research Demonstrating Clinically Significant Reductions in Depression Through its Digital Behavioral Health Programs
63% of members using the Dario platform saw significant reduction in depression and anxiety symptoms NEW YORK , Sept. 27, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company...
Dario Publishes New Research Demonstrating Greater Engagemenet and Improved Clinical Outcomes Sustainable for Two Years
New research presented at ADCES23 links engagement in Dario's digital health solutions with improved outcomes NEW YORK , Aug. 24, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the ...
Dario Partners with PlanSource to Offer Employers Easy Access to Proven Digital Health Solutions
New agreement expands Dario's reach in the employer market with access to more than 5 million consumers NEW YORK , Aug. 15, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Compa...
DarioHealth Reports Second Quarter 2023 Financial and Operating Results
- Generated sequential B2B recurring revenue growth for the tenth consecutive quarter - Revenues of $6.15 million (pre-announced), compared to $6.18 million in the second quarter of 2022, a 0.5% decre...